|
287 Financial
support for training and IM&T in Scotland Pharmacy contractors
in Scotland are to be given financial support to help them prepare for
the new community pharmacy contract, due to be implemented in April 2006
...more
287 Prescription
charges change Prescription charges are to go up by 10p to £6.50 on 1 April in Scotland. In Wales, the prescription charge will be cut
...more
287 PCTs
to issue penalty notices Primary care trusts in England are
to take responsibility for checking up on fraudulent prescription charge
exemption claims and issuing penalty notices from 1 April. They will
be allowed to retain the income generated ...more
287 Hospital
admission MRSA tests to be piloted Rapid testing of patients
on admission to hospital for methicillin resistant Staphylococcus
aureus (MRSA) is to be piloted at two UK sites. However, questions remain over
what treatment should be offered on the basis of the results ...more
287 Thirty pharmacists seek to join Society’s new Council Thirty candidates are contesting the 17 elected places for pharmacists on the Royal Pharmaceutical Society’s reformed Council and three candidates are seeking to fill the new Council’s two places for registered pharmacy technicians
...more
288 Expert
patients have reduced symptoms of illness Expert patients
are more confident about looking after themselves, consult GPs less often,
have reduced symptoms of illness and use pharmacy services more ...more
288 Ministers
told pharmacists need clinical data Pharmacists need access
to clinical information about patients via the NHS Care Records Service
to enable them to carry out new roles such as supplementary prescribing.
They will also need access to NHS e-mail addresses to allow effective
communication with other members of the primary care team ...more
288 Ordering
systems in hospitals increase medication errors Computerised
systems for ordering medicines in a hospital setting can increase the
risk of adverse drug events, says new research from the US ...more
288 Price
competition criticised Price competition between pharmacies
has been criticised in The Times after the newspaper found that the cost
of having a private prescription dispensed could vary dramatically ...more
289 Regulations
guidance explains entry test exemptions Draft guidance for
primary care trusts in England on implementing the forthcoming NHS regulations
explains how new exemptions to the control of entry test should be applied.
As a general rule, any new pharmacy must be necessary or desirable to
secure adequate pharmaceutical services in a particular neighbourhood.
But the new contract introduces four exemptions ...more
289 Pharmacists
in Wales to declare interests Pharmacists working for the
NHS in Wales, whether as employees or primary care contractors, are expected
to declare any shareholdings in pharmaceutical companies under guidance
published last week ...more
289 Avandamet
shortages likely after manufacture problems Avandamet, GlaxoSmithKline’s
recently launched type 2 diabetes treatment, is expected to be in short
supply in the UK within the next two weeks. A GSK spokesman confirmed
that quality control problems were disrupting manufacture in Puerto Rico ...more
289 Generics
company executives expected to face fraud charges Executives
of various generics companies are likely to face criminal charges following
an extended investigation by the Serious Fraud Office ...more
289 First counter
fraud graduates The first counter fraud graduates received
their degree certificates this week ...more
|
290 New HIV drugs
urgently needed for HAART patients New drugs that are not
associated with cross-resistance are urgently needed for patients on
highly active antiretroviral therapy (HAART), researchers say ...more
290 Treat co-infected
HIV patients for hepatitis C In Europe, some 30 per cent of
patients with HIV infection are co-infected with hepatitis C virus. At
present, few patients receive treatment for hepatitis C but a European
consensus statement issued last week emphasises the importance of treatment
...more
290 Limited evidence
for cranberries in UTIs, says DTB review Cranberry-containing
products cannot currently be recommended for the prevention of recurrent
urinary tract infections in women, according to the latest Drug and
Therapeutics Bulletin review ...more
290 SMC recommends
letrozole but rejects five others Letrozole (Femara) was recommended
for use in NHS Scotland this week by the Scottish Medicines Consortium.
However, it rejected a number of other drugs ...more
291 Beta-blocker
combinations for raised BP questioned Serious doubts have
been raised over the use of beta-blocker and diuretic combinations in
hypertension by data from a huge UK study ...more
291 Aspirin fails
to reduce women’s risk of first MI Low-dose aspirin
does not decrease the risk of women having a first heart attack or of
dying from cardiovascular events, say researchers ...more
291 Intensive
statin therapy benefit in stable CHD patients Patients with
stable coronary heart disease benefit more from intensive than standard
lipid-lowering therapy, new data suggest ...more
291 Arrhythmia
NSF chapter launched A chapter on arrhythmias and sudden cardiac
death has been added to the National Service Framework for Coronary Heart
Disease ...more
291 Atherothrombosis
undertreated Atherothrombosis is undertreated worldwide, data
presented at the American College of Cardiology meeting this week suggest
...more
291 Tamoxifen
and endometrial cancer Endometrial cancer risk rises with
duration of tamoxifen treatment, a study of 1,880 women with breast cancer
has found ...more
R&D news
292 Role for
thalidomide in prevention of weight loss in cancer patients Patients
with cancer who are experiencing a significant loss of body weight could
have a new treatment option in the future in the form of thalidomide
...more
292 Cannabis-based
medicine reduces cancer pain Preliminary results of a phase
III trial of the cannabis-based medicine Sativex have shown the product
to be effective in reducing pain associated with cancer, according to
GW Pharmaceuticals, the company developing the drug ...more
292 Quetiapine benefit in Alzheimer’s The antipsychotic drug quetiapine (Seroquel; AstraZeneca) may benefit patients with Alzheimer’s disease according to new data from AstraZeneca
...more
292 Single injection
cures liver disease Rats with an inherited liver disease have
been successfully treated with a single injection of a gene carried by
an adenovirus ...more
|
The
Pharmaceutical Journal